Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Guardant Health Inc.

    NASDAQ: GH · Real-Time Price · USD
    52.06
    1.20 (2.36%)
    At close: Jun 30, 2025, 3:59 PM
    51.21
    -1.64%
    Pre-market: Jul 01, 2025, 09:20 AM EDT

    Guardant Health Statistics

    Share Statistics

    Guardant Health has 123.89M shares outstanding. The number of shares has increased by 0.7% in one year.

    Shares Outstanding

    n/a
    		 123.89M

    Shares Change (YoY)

    n/a
    		 0.7%

    Shares Change (QoQ)

    n/a
    		 0.38%

    Owned by Institutions (%)

    n/a
    		 97.11%

    Shares Floating

    n/a
    		 117.68M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,821

    FTD / Avg. Volume

    n/a
    		 0.08%

    Short Selling Information

    The latest short interest is 10M, so 8.07% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 10M

    Short % of Shares Out

    n/a
    		 8.07%

    Short % of Float

    n/a
    		 8.47%

    Short Ratio (days to cover)

    n/a
    		 4.06

    Valuation Ratios

    The PE ratio is -8.59 and the forward PE ratio is -21.88. Guardant Health's PEG ratio is 0.51.

    PE Ratio

    n/a
    		 -8.59

    Forward PE

    n/a
    		 -21.88

    PS Ratio

    n/a
    		 5.07

    Forward PS

    n/a
    		 3.8

    PB Ratio

    n/a
    		 -26.85

    P/FCF Ratio

    n/a
    		 -13.64

    PEG Ratio

    n/a
    		 0.51
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Guardant Health.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.68, with a Debt / Equity ratio of -9.57.

    Current Ratio

    n/a
    		 4.68

    Quick Ratio

    n/a
    		 4.36

    Debt / Equity

    n/a
    		 -9.57

    Debt / EBITDA

    n/a
    		 -3.42

    Debt / FCF

    n/a
    		 -4.86

    Interest Coverage

    n/a
    		 -171.87

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $369,692.85

    Profits Per Employee

    n/a
    		 $-218,295.65

    Employee Count

    n/a
    		 1,999

    Asset Turnover

    n/a
    		 0.5

    Inventory Turnover

    n/a
    		 4.08

    Taxes

    Income Tax

    n/a
    		 1.28M

    Effective Tax Rate

    n/a
    		 -0.3%

    Stock Price Statistics

    The stock price has increased by 84.22% in the last 52 weeks. The beta is 1.38, so Guardant Health's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.38

    52-Week Price Change

    n/a
    		 84.22%

    50-Day Moving Average

    n/a
    		 45.1

    200-Day Moving Average

    n/a
    		 37.49

    Relative Strength Index (RSI)

    n/a
    		 69.36

    Average Volume (20 Days)

    n/a
    		 2,274,643

    Income Statement

    In the last 12 months, Guardant Health had revenue of 739.02M and earned -436.37M in profits. Earnings per share was -3.56.

    Revenue

    n/a
    		 739.02M

    Gross Profit

    n/a
    		 449.22M

    Operating Income

    n/a
    		 -443.59M

    Net Income

    n/a
    		 -436.37M

    EBITDA

    n/a
    		 -390.12M

    EBIT

    n/a
    		 -432.51M

    Earnings Per Share (EPS)

    n/a
    		 -3.56
    Full Income Statement

    Balance Sheet

    The company has 525.54M in cash and 1.34B in debt, giving a net cash position of -810.51M.

    Cash & Cash Equivalents

    n/a
    		 525.54M

    Total Debt

    n/a
    		 1.34B

    Net Cash

    n/a
    		 -810.51M

    Retained Earnings

    n/a
    		 -2.58B

    Total Assets

    n/a
    		 1.34B

    Working Capital

    n/a
    		 701.27M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -239.86M and capital expenditures -35.09M, giving a free cash flow of -274.94M.

    Operating Cash Flow

    n/a
    		 -239.86M

    Capital Expenditures

    n/a
    		 -35.09M

    Free Cash Flow

    n/a
    		 -274.94M

    FCF Per Share

    n/a
    		 -2.24
    Full Cash Flow Statement

    Margins

    Gross margin is 60.79%, with operating and profit margins of -60.02% and -59.05%.

    Gross Margin

    n/a
    		 60.79%

    Operating Margin

    n/a
    		 -60.02%

    Pretax Margin

    n/a
    		 -58.87%

    Profit Margin

    n/a
    		 -59.05%

    EBITDA Margin

    n/a
    		 -52.79%

    EBIT Margin

    n/a
    		 -60.02%

    FCF Margin

    n/a
    		 -37.2%

    Dividends & Yields

    GH does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for GH is $56, which is 7.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $56

    Price Target Difference

    n/a
    		 7.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 20
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -0.82

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist